Study on the influence of caffeic acid against sodium valproate-induced nephrotoxicity in rats.
Amany M GadPublished in: Journal of biochemical and molecular toxicology (2018)
Renal injury is a hallmark adverse reaction to sodium valproate (SVP), and caffeic acid (CAFF) is a phenolic compound that has anti-inflammatory and antioxsidant properties. So, this investigation was assessed to evaluate the nephrotoxic potential of SVP and the defensive impact of CAFF against SVP nephrotoxicity. SVP was given at a dose of 500 mg/kg (i.p.) once daily for 2 weeks, while CAFF was given at a dose of 50 mg/kg (orally), simultaneously with SVP. Concurrent treatment with CAFF reduced urea and creatinine, lipid peroxidation (malondialdehyde), tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), nuclear factor kappa B (NF-κB/p65), and transforming growth factor β (TGF-β) levels. However, with increased glutathione content, CAFF also halted the activated Notch signaling cascade. Furthermore, CAFF suppressed caspase-3 and inducible nitric oxide synthase expressions. To conclude, on the basis of the results obtained, CAFF proved to protect against SVP-induced nephrotoxicity via its antioxidant, anti-inflammatory, and antiapoptotic properties.
Keyphrases
- nuclear factor
- transforming growth factor
- anti inflammatory
- drug induced
- toll like receptor
- nitric oxide synthase
- epithelial mesenchymal transition
- high glucose
- diabetic rats
- nitric oxide
- rheumatoid arthritis
- dendritic cells
- oxidative stress
- immune response
- signaling pathway
- endothelial cells
- squamous cell carcinoma
- combination therapy
- fatty acid
- inflammatory response
- pi k akt
- lps induced
- risk assessment
- metabolic syndrome
- induced apoptosis
- smoking cessation